TP53 and B-cell chronic lymphocytic leukemia: Here we studied 150 CLL samples and concentrated on the questions (i) if i(17q) can be detected reliably by MLPA and (ii) if i(17q) presence in patients with TP53 deletion is associated with more complex cytogenetic aberrations.